Bases genéticas del cáncer

Webster K. Cavenee , Raymond L. White
Investigación y ciencia ( 224) 44 -51

2
1995
Analysis of Replication Error (RER+) Phenotypes in Cervical Carcinoma

Suzanne Kern , Amy A. Larson , Jun Yokota , Garret M. Hampton
Cancer Research 56 ( 6) 1426 -1431

45
1996
Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks

Jill Wykosky , Webster K. Cavenee , Ciro Zanca , Frank B. Furnari
Cancer biology and medicine 10 ( 4) 192 -205

34
2013
Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo

Ralf F. Pettersson , A. Jonas Ekstrand , C. David James , V. Peter Collins
Cancer Research 51 ( 8) 2164 -2172

821
1991
Muscle-specific Gene Expression in Rhabdomyosarcomas and Stages of Human Fetal Skeletal Muscle Development

Hiroyuki Shimada , Patricia N. Tonin , Heidi Scrable , Webster K. Cavenee
Cancer Research 51 ( 19) 5100 -5106

95
1991
Muscle-specific Gene Expression in Rhabdomyosarcomas and Stages of Human Fetal Skeletal Muscle Development

Hiroyuki Shimada , Patricia N. Tonin , Heidi Scrable , Webster K. Cavenee
Cancer Research 51 ( 19) 5100 -5106

95
1991
Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance

Paul S. Mischel , Timothy Cloughesy , Jun-Feng Bi , Webster K. Cavenee
Cancer biology and medicine 11 ( 4) 255 -263

28
2014
Silencing of p16/CDKN2 Expression in Human Gliomas by Methylation and Chromatin Condensation

Joseph F. Costello , Mitchel S. Berger , H-J. Su Huang , Webster K. Cavenee
Cancer Research 56 ( 10) 2405 -2410

235
1996
Genetics of cancer predisposition.

Marc F. Hansen , Webster K. Cavenee
Cancer Research 47 ( 21) 5518 -5527

173
1987
380
1996
High resolution analysis of chromosome 3p alterations in cervical carcinoma

Suzanne Kern , Amy A. Larson , Robert Gordon , Garret M. Hampton
Cancer Research 57 ( 18) 4082 -4090

52
1997
The Phosphoinositol Phosphatase Activity of PTEN Mediates a Serum-sensitive G1 Growth Arrest in Glioma Cells

H-J. Su Huang , Webster K. Cavenee , Frank B. Furnari
Cancer Research 58 ( 22) 5002 -5008

359
1998
Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.

Karen C. Arden , Rudolf A. Herbst , Jürgen Weiss , Webster K. Cavenee
Cancer Research 54 ( 12) 3111 -3114

169
1994
D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.

Karen C. Arden , Karen E. Knudsen , Webster K. Cavenee
Cancer Research 59 ( 10) 2297 -2301

178
1999
169
1999
Cyclin-dependent Kinase 6 (CDK6) Amplification in Human Gliomas Identified Using Two-dimensional Separation of Genomic DNA

Verne M. Chapman , William A. Held , Joseph F. Costello , Joseph F. Costello
Cancer Research 57 ( 7) 1250 -1254

176
1997
Genetic Alterations Accumulate during Cervical Tumorigenesis and Indicate a Common Origin for Multifocal Lesions

Eric J. Stanbridge , Amy A. Larson , Shu-Yuan Liao , Garret M. Hampton
Cancer Research 57 ( 19) 4171 -4176

67
1997
Loss of Wild-Type p53 Bestows a Growth Advantage on Primary Cortical Astrocytes and Facilitates Their in Vitro Transformation

Oliver Bögler , H. J Su Huang , Webster K. Cavenee
Cancer Research 55 ( 13) 2746 -2751

62
1995
Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors

Anil Nanda , H-J. Su Huang , Webster K. Cavenee , Yuchun Han
Cancer Research 56 ( 17) 3859 -3861

118
1996